WallStSmart
ADTX

Aditxt Inc.

NASDAQ: ADTX · HEALTHCARE · BIOTECHNOLOGY

$0.22
-0.73% today

Updated 2026-04-29

Market cap
$196180.00
P/E ratio
P/S ratio
61.40x
EPS (TTM)
$-9,230.64
Dividend yield
52W range
$0 – $2,495
Volume
1.8M

Aditxt Inc. (ADTX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$105034.00$933715.00$645176.00$133985.00$3.19M
Revenue growth (YoY)+789.0%-30.9%-79.2%+2284.6%
Cost of revenue$17773.00$77979.00$766779.00$756836.00$627474.00$2.93M
Gross profit$-17773.00$27055.00$166936.00$-111660.00$-493000.00$268000.00
Gross margin25.8%17.9%-17.3%-368.0%8.4%
R&D$525000.00$175441.00$937966.00$5.04M$7.27M$7.07M$10.89M$3.19B
SG&A$851944.00$5.04M$5.69M$7.85M$22.08M$15.99M$18.61M$16.29M$15.97B
Operating income$-213000.00$-5.61M$-5.87M$-8.87M$-41.94M$-25.48M$-26.06M$-27.86M$-19.57B
Operating margin-39925.2%-2728.9%-4039.6%-20796.4%-612542.2%
EBITDA$638958.00$-5.61M$-5.87M$-8.82M$-43.96M$-24.83M$-25.46M$-27.04M$-19.30M
EBITDA margin-41850.3%-2659.1%-3945.9%-20180.6%-604.0%
EBIT$-212986.00$-5.61M$-5.87M$-8.84M$-44.43M$-25.36M$-26.00M$-27.66M$-19.57M
Interest expense$0.00$79766.00$1930.00$310081.00$1.94M$2.29M$6.39M$7.36M$2.39M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-213000.00$-5.69M$-5.83M$-9.15M$-46.37M$-27.65M$-32.38M$-34.45M$-43.10B
Net income growth (YoY)-2571.0%-2.5%-56.9%-406.8%+40.4%-17.1%-6.4%-125027.6%
Profit margin-44148.6%-2961.3%-5018.9%-25708.8%-1349028.2%